AI governance is the set of policies, controls, roles, and oversight processes an organization uses to manage how artificial intelligence is selected, deployed, monitored, and retired. In healthcare, the answer is usually yes: if your organization uses AI for documentation, coding, scheduling, patient communications, utilization review, revenue cycle, clinical support, or any tool that touches protected health information, billing, or patient care, you likely need a formal AI governance process.
What is AI governance in healthcare?
AI governance is a structured framework for making sure AI is used safely, lawfully, ethically, and consistently. In a healthcare setting, that means more than general IT management. It requires oversight for privacy, security, data quality, clinical safety, billing integrity, vendor risk, workforce use, and compliance with federal and state requirements.
AI governance is not one document. It is an operating model that defines:
- Who can approve AI tools
- What due diligence must happen before use
- How data can be used, disclosed, stored, and protected
- What human review is required
- How outputs are validated for accuracy and bias
- How incidents, errors, and model drift are detected and addressed
- When a tool must be limited, suspended, or retired
Healthcare organizations should assume that AI creates compliance risk even when a product is marketed as an efficiency tool rather than a clinical device.
Why does a healthcare company need AI governance now?
Healthcare organizations are adopting AI faster than many internal control structures can keep up. Common uses include ambient documentation, generative AI drafting, coding support, chatbot triage, denial management, prior authorization support, and predictive analytics. Each of these functions can affect protected health information, payment accuracy, and patient outcomes.
Several legal and regulatory trends make AI governance especially important:
- HIPAA still applies. The HIPAA Privacy Rule and Security Rule apply when AI tools create, receive, maintain, or transmit protected health information. Covered entities and business associates must comply with the administrative, physical, and technical safeguard requirements at 45 CFR Part 164, Subpart C, and use or disclose PHI only as permitted under 45 CFR Part 164, Subpart E.
- OCR has warned against impermissible data disclosures through tracking technologies. That guidance underscores a broader point: using modern digital tools does not remove HIPAA obligations, especially when data flows to vendors or third parties. See HHS OCR materials on web tracking and HIPAA compliance at HHS.gov.
- OIG has identified compliance risks tied to new technology. The HHS Office of Inspector General has issued compliance guidance emphasizing oversight, auditing, and internal controls. Even where guidance is not AI-specific, it applies to billing, quality, and fraud-risk implications from automated tools. See OIG General Compliance Program Guidance, published November 2023, at oig.hhs.gov.
- The FDA regulates certain AI-enabled medical devices. If an AI tool performs diagnostic or treatment-related functions, it may fall within FDA oversight as software functions or software as a medical device. See FDA resources on AI/machine learning-enabled medical devices at fda.gov.
- Civil rights and discrimination rules can apply. HHS has highlighted the risk that clinical algorithms and automated systems may contribute to discriminatory outcomes. Section 1557 of the Affordable Care Act and broader civil rights obligations may be implicated if AI affects access, prioritization, or quality of care in a biased way.
- The FTC has also been active on AI claims and automated decision-making. Organizations should not assume that vendor marketing statements about accuracy, de-identification, or fairness are legally sufficient. See FTC business guidance on AI at ftc.gov.
In short, healthcare companies need AI governance because AI can change how decisions are made, how PHI is handled, and how claims are created or supported. Those are core compliance functions.
What should an AI governance program include?
1. Governance structure and accountability
Create a formal review and oversight process. Many organizations assign responsibility to a cross-functional committee that includes compliance, privacy, security, legal, clinical leadership, revenue cycle, IT, and operations.
- Define who approves AI use cases
- Assign an executive owner
- Document roles for monitoring and escalation
- Require board or senior leadership visibility for higher-risk tools
2. AI inventory and classification
You cannot govern what you have not identified. Maintain an inventory of AI systems, including embedded AI features in EHRs, clearinghouses, call center systems, coding platforms, and productivity software.
- List the vendor, product, function, data sources, users, and outputs
- Classify each tool by risk: administrative, financial, operational, clinical, or patient-facing
- Note whether PHI, payment data, or medical decision support is involved
3. Vendor due diligence and contracting
Vendor review should go beyond standard IT procurement. Healthcare organizations should evaluate:
- Whether the vendor is a business associate and whether a BAA is required
- How the model is trained and whether customer data is used for further training
- What security controls, logging, and access restrictions exist
- Whether the vendor provides validation evidence, limitations, and known failure modes
- How data is retained, deleted, or segregated
- Whether subcontractors are involved
Contract terms should address use restrictions, data ownership, audit rights, incident reporting, indemnification where appropriate, and required cooperation for regulatory inquiries.
4. Privacy and security controls
If an AI tool touches PHI, HIPAA analysis is essential. At minimum, organizations should perform a security risk analysis consistent with 45 CFR 164.308(a)(1) and evaluate the minimum necessary standard where applicable.
- Limit inputs to the minimum necessary data
- Restrict workforce access by role
- Disable public or consumer AI tools for PHI unless specifically approved
- Require encryption, logging, and authentication controls
- Address retention and deletion in line with policy and contract terms
5. Validation, human oversight, and quality assurance
AI outputs can be incomplete, biased, or wrong. That matters if the tool drafts medical records, suggests codes, prioritizes work queues, or supports clinical decision-making.
- Test outputs before production use
- Define what must be reviewed by a human and by whom
- Prohibit blind reliance on AI-generated content
- Audit samples for accuracy, consistency, and downstream impact
- Monitor for model drift or changes after updates
For revenue cycle uses, this is especially important because inaccurate automation can create overpayments, underpayments, or false claims exposure.
6. Workforce policy and training
Many AI risks begin with informal employee use. Staff need clear rules on what they may and may not do.
- State whether public generative AI tools may be used for work tasks
- Forbid entry of PHI into unapproved tools
- Require disclosure when AI is used in certain workflows
- Train employees on verification, bias, and documentation standards
- Include sanctions for unauthorized use
7. Incident response and ongoing monitoring
AI governance should connect to compliance, privacy, and security incident response. Issues may include data leakage, hallucinated content in records, discriminatory outputs, or unsupported billing recommendations.
- Create a reporting pathway for AI-related concerns
- Track errors, overrides, complaints, and adverse events
- Reassess high-risk tools periodically
- Pause or retire tools that no longer meet requirements
What are the main legal risks of using AI in healthcare?
The biggest risks usually fall into five categories:
- HIPAA violations: impermissible disclosures, inadequate safeguards, missing BAAs, or overbroad data sharing
- Billing and False Claims Act exposure: AI-assisted coding or documentation that creates unsupported claims
- Patient safety risk: inaccurate outputs used in care decisions or triage
- Discrimination and bias: automated systems producing unequal access, prioritization, or outcomes
- Consumer protection and contract risk: reliance on vendor claims that are unverified or misleading
These risks do not mean healthcare organizations should avoid AI. They mean AI should be governed with the same seriousness applied to privacy, security, and billing compliance.
How can a healthcare organization start building AI governance?
A practical starting point is to begin with policy, inventory, and risk review before expanding to more mature controls.
- Identify all current AI and AI-enabled tools
- Pause unapproved use cases involving PHI or claims
- Adopt an interim AI use policy for the workforce
- Create a cross-functional review group
- Perform vendor and HIPAA risk review for priority tools
- Define human-review requirements for outputs
- Implement monitoring and periodic audits
For many organizations, the immediate issue is not advanced model governance. It is simply creating enough visibility and control to know where AI is already being used and what risks it creates.
Does every healthcare company need a formal AI governance program?
If your organization uses AI only in very limited, low-risk administrative ways, your framework may be simple. But some level of AI governance is still appropriate because AI tools can evolve quickly, become embedded in vendor products, and affect regulated data and processes without much notice.
As a rule, the more an AI system influences documentation, coding, reimbursement, patient interaction, utilization management, or clinical decisions, the more formal your governance structure should be.
AI governance is becoming a basic healthcare compliance function. It helps organizations use new technology while protecting patients, supporting accurate billing, and meeting privacy and security obligations.